TNYA
Tenaya Therapeutics, Inc.
$0.79
+0.04 (+5.50%)
At close · Jul 2
Market Cap
$170.76M
Shares
216,998,876
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-06-04 | Jefferies Global Healthcare Conference | Conference |
| 2026-06-03 | Interim Data from the MyPEAK-1 Phase 1b/2 Trial of TN-201 for Adults with MYBPC3-Associated Hypertrophic Cardiomyopathy | Event |
| 2026-05-15 | Data from RIDGE-1 Phase 1b/2 Clinical Trial of TN-401 in Adults with PKP2-associated ARVC Presented at ASGCT 2026 | Event |
| 2026-03-09 | Leerink Global Healthcare Conference | Conference |
| 2025-12-11 | Interim Data from RIDGE-1 Phase 1b Clinical Trial of TN-401 in Adults with PKP2-associated ARVC | Event |
| 2025-11-10 | Interim Clinical Data from MyPEAK-1 Evaluating Safety and Early Efficacy of TN-201 in Adult Patients with MYBPC3-Associated HCM | Event |
| 2025-10-14 | H.C. Wainwright Genetic Medicines Virtual Conference | Conference |
| 2025-09-09 | Morgan Stanley 23rd Annual Global Healthcare Conference | Conference |
| 2025-08-26 | Measuring Protein Expression in Cardiac Gene Therapy - KOL Webcast Event | Webcast |
| 2025-08-12 | Canaccord Genuity 45th Annual Growth Conference | Conference |